Pharmacokinetics of a new oral formulation of amoxicillin

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 22, Issue 1, 1997, Pages 47-52

  Prevot, M H ^a,c   Jehl, F ^b   Rouveix, B ^a  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSERM   (France)

Author keywords

Amoxicillin; Bioavailability; Pharmacokinetics

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; TABLET;

EID: 0030980833     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189784     Document Type: Article

References (35)

1. Macfarlane J.T. (1987): Treatment of lower respiratory infections. Lancet, II, 1446-1449.
2. Appelbaum P.C. (1992): Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis., 15, 77-83.
3. Doem G.V. (1994): Emergence of antimicrobial resistance with Streptococcus pneumoniae, Haemophilus influenzae and Neisseria species. 34th Interscience Conference on Antimicrobial Agent and Chemotherapy. Orlando. S91(C), 288.
4. Klugman K.P. (1994): Management of antibiotic-resistant pneumococcal infections. J. Antimicrob. Chemother., 33, 191-193.
5. Gibaldi M., Perrier D. (Eds) (1982): Pharmacokinetics. New York: Marcel Dekker, 451-457.
6. Westlake W.J. (1976): Symmetrical confidence intervals for bioequivalence trials. Biometrics, 32, 741-744.
7. Schuirmann D.J. (1987): A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharm. Biopharm., 15, 657-680.
8. Steinijans V.W., Hauschke D., Jonkman J.H.G. (1992): Controversies in bioequivalence studies. Clin. Pharmacokinet., 22, 247-253.
9. Spyker D.A., Rugloski R.J., Vann R.L., O'Brien W.M. (1977): Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration. Antimicrob. Agents Chemother., 11, 132-141.
10. Bodey G.P., Nance J. (1972): Amoxicillin: in vitro and pharmacological studies. Antimicrob. Agents Chemother., 1, 358-362.
11. Duval J., Soussy C.J. (1973): Activité antibactérienne et pharmacocinétique de l'amoxicilline. Comparaison avec l'ampicilline. Med. Malad. Infect., 12, 525-531.
12. Croydon E.A.P., Sutherland R. (1970): α-Amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man. Antimicrob. Agents Chemother., 4, 427-430.
13. Sutherland R., Croydon E.A.P., Rolinson G.N. (1972): Amoxicillin: a new semisynthetic penicillin. BMJ, 3, 13-16.
14. Hespe W., Verschoor J.S.C., Olthoff M. (1987): Bioavailability of new formulations of amoxicillin in relation to its absorption kinetics. Arzneimittelforschung., 37, 372-375.
15. Comité de l'antibiogramme de la société française de microbiologie (1994), Path. Biol., 42, 8, I-VIII.
16. Welling P.B., Huang H., Koch P.A., Craig W.A., Madsen P.O. (1977): Bioavailability of ampicillin and amoxicillin in fasted and non fasted subjects. J. Pharm. Sci., 66, 549-552.
17. Westphal J.F., Deslandes A., Brogard J.M., Carbon C. (1991): Reappraisal of amoxicillin absorption kinetics. J. Antimicrob. Chemother., 27, 647-654.
18. Sjóvall J. (1979): Dose dependence in human absorption of aminopenicillins. Infection, 7, S458-S462.
19. Sjövall J., Alvan G., Westerlund D. (1985): Dose-dependant absorption of amoxicillin and bacampicillin. Clin. Pharmacol. Ther., 38, 241-250.
20. Sjövall J., Alvan G., Akerlund J.E. et al. (1992): Dose-dependant absorption of amoxicillin in patients with an ileostomy. Eur. J. Clin. Pharmacol., 43, 277-281.
21. Paintaud G., Alvan G., Dahl M.L., Grahnen A., Sjövall J., Svensson J.O. (1992): Nonlinearity of amoxicillin absorption kinetics in human. Eur. J. Clin. Pharmacol., 43, 283-288.
22. Vogelman B., Craig W.A. (1986): Kinetics of antimicrobial activity. J. Pediatr., 108, 835-840.
23. Vogelman B., Gudmundsson S., Legett J., Turnidge J., Ebert S., Craig W.A. (1988): Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis., 158, 831-847.
24. Legett J., Fantin B., Ebert S. et al. (1989): Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis., 159, 281-292.
25. Drusano G.L. (1988): Role of pharmacokinetics in the outcome of infections. Antimicrob. Agents Chemother., 32, 289-297.
26. Bundtzen R.W., Gerber A.U., Cohn D.L., Craig W.A. (1981): Postantibiotic suppression of bacterial growth. Rev. Infect. Dis., 3, 28-37.
27. Bennett S., Vogelman B., Craig W.A. (1985): Postantibiotic effects. J. Antimicrob. Chemother., 15, S37-S46.
28. Vogelman B., Gudmundsson S., Turnidge J., Legett J., Craig W.A. (1988): In vivo postantibiotic effect in a thigh infection in neutropenic mice. J. Infect. Dis., 157, 287-298.
29. Leng B.M., Lacut J.Y., Aubertin J.M. (1976): Pharmacokinetics of amoxycillin according to administration schedule. J. Int. Med. Res., 4, 449-453.
30. Neu H.C. (1981): Current practices in antimicrobial dosing. Rev. Infect. Dis., 3, 12-18.
31. Kunin C.M. (1981): Dosage schedules of antimicrobial agents: a historical review. Rev. Infect. Dis., 3, 4-11.
32. Bakker-Woundenberg I.A.J.M., Van der Berg J.C., Fontijne P., Michel M.F. (1984): Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats. Eur. J. Clin. Microbiol., 3, 131-135.
33. Norbring F. (1981): Current practice in penicillin dosing. J. Antimicrob. Chemother., 8, S1-S6.
34. Moreno F., Crisp C., Jorgensen J.H., Patterson J.E. (1994): The clinical and molecular epidemiology of bacteremia due to Streptococcus pneumoniae isolates not susceptible to penicillin at a University Hospital. 34th Interscience Conference on Antimicrobial Agent and Chemotherapy. Orlando., S41, C10.
35. Bedos J.P., Vallée E., Moine P., Chastang CI. (1994): A two years' survey of Streptococcus pneumoniae (Sp) isolates in Bichat-Claude Bernard Hospital, Paris, France: epidemiology data, risk factors of infection by penicillin nonsensitive strains. 34th Interscience Conference on Antimicrobial Agent and Chemotherapy. Orlando., S41, C12.